July 22, 2026

Treatment Delays May Increase Metastasis Risk in Nonmetastatic Colorectal Cancer

In a cohort study of patients with nonmetastatic colorectal cancer, treatment delays were associated with a higher risk of metastasis, with the magnitude differing by treatment pathway.

The ASCO Post

July 22, 2026

Treatment Delays May Increase Metastasis Risk in Nonmetastatic Colorectal Cancer

In a cohort study of patients with nonmetastatic colorectal cancer, treatment delays were associated with a higher risk of metastasis, with the magnitude differing by treatment pathway.

The ASCO Post

July 17, 2026

ctDNA Status May Predict Benefit From Adjuvant Chemotherapy After Resection of Colorectal Liver Metastases

Circulating tumor DNA (ctDNA) for molecular residual disease tracking could help identify patients with colorectal cancer and liver metastases who are most likely to benefit from adjuvant chemotherapy...

The ASCO Post

July 13, 2026

Perioperative Systemic Therapy vs Surgery Alone in Colorectal Peritoneal-Only Metastases

In a phase III trial (CAIRO6) reported in The Lancet Oncology, Rovers et al found that perioperative systemic therapy was not associated with significant improvement in overall survival vs surgery alo...

The ASCO Post

July 13, 2026

Perioperative Systemic Therapy vs Surgery Alone in Colorectal Peritoneal-Only Metastases

In a phase III trial (CAIRO6) reported in The Lancet Oncology, Rovers et al found that perioperative systemic therapy was not associated with significant improvement in overall survival vs surgery alo...

The ASCO Post

July 08, 2026

GLP-1 Receptor Agonists Linked to Lower Colorectal Cancer Risk in Patients With IBD

A large retrospective cohort study explored whether use of GLP-1 receptor agonists by patients with inflammatory bowel disease (IBD) was associated with lower 5-year rates of colorectal cancer. The re...

The ASCO Post

July 07, 2026

Baptist Health Cancer Care to Present Research on Precision Radiation Therapy Across Complex Cancers at ASTRO 2026

Experts across Baptist Health Herbert Wertheim Cancer Institute and Eugene M. & Christine E. Lynn Cancer Institute will present new radiation oncology research and clinical expertise at the 2026 Annual Meeting of the American Society for Radiation Oncology (ASTRO), September 26-30, 2026, in Boston.

Baptist Health South Florida

July 07, 2026

Early Research Explores How Fatty Liver Disease May Affect Liver Metastasis Among Patients With Colorectal Cancer

Investigators found treatment-naive patients with colorectal cancer and liver steatosis have an increased occurrence of replacement metastases—where cancer cells infiltrate and interact with healthy l...

The ASCO Post

July 07, 2026

Impact of Treatment Delays in Early-Onset Colorectal Cancer

In a retrospective, population-based, cross-sectional study reported in JAMA Oncology, Heslin et al found that treatment delay in early age–onset colorectal cancer was associated with poorer overall s...

The ASCO Post

June 22, 2026

Metastatic Colorectal Cancer: GUCY2C-Targeted CAR T-Cell Therapy

In a Chinese phase I dose-escalation and dose-expansion study reported in the Journal of Clinical Oncology, Qi et al found that guanylyl cyclase 2C (GUCY2C)–targeted CAR T-cell therapy had an ‘accepta...

The ASCO Post